SCHEMBL969403

SCHEMBL969403

CCN1CCN(C(=O)CN2CCc3c([nH]c4ccccc34)C2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.64
KDM4E B2RXH2 3/20 0.64
HPGD P15428 1/20 0.64
DRD2 P14416 1/20 0.57
DRD1 P21728 1/20 0.57
DRD4 P21917 1/20 0.57
DRD5 P21918 1/20 0.57
GPX4 P36969 1/20 0.57
HTR1A P08908 1/20 0.56
MAPT P10636 3/20 0.54
GAA P10253 1/20 0.54
CASP1 P29466 2/20 0.53
CASP7 P55210 2/20 0.53
GRIN2B Q13224 1/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
ALOX15 P16050 1/20 0.53
HDAC1 Q13547 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
SIGMAR1 Q99720 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL969021 0.91 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDGPX4HTR1A
SCHEMBL968675 0.89 HTR1A (0.66) ALDH1A1KDM4EHPGDGPX4HTR1A
SCHEMBL967406 0.89 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDDRD2GPX4
SCHEMBL967361 0.88 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDDRD2GPX4
SCHEMBL969099 0.88 ALDH1A1 (0.69) ALDH1A1KDM4EHPGDDRD2GPX4
SCHEMBL967323 0.87 ALDH1A1 (0.71) ALDH1A1KDM4EHPGDDRD2GPX4
SCHEMBL969372 0.86 KDM4E (0.67) ALDH1A1KDM4EHPGDDRD2GPX4
SCHEMBL968991 0.86 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDDRD2GPX4
SCHEMBL970364 0.86 HTR1A (0.61) ALDH1A1KDM4EHPGDDRD2GPX4
SCHEMBL968842 0.85 KDM4E (0.69) ALDH1A1KDM4EHPGDDRD2GPX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US claimed
EP-2162451-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES Neurogen Corporation (US) 2010-03-17 EP claimed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO claimed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 ALDH1A1 812/4885KDM4E 3037/4885HPGD 606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.